Cite
Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19.
MLA
Hamilton, William L., et al. “Applying Prospective Genomic Surveillance to Support Investigation of Hospital-Onset COVID-19.” The Lancet. Infectious Diseases, vol. 21, no. 7, July 2021, pp. 916–17. EBSCOhost, https://doi.org/10.1016/S1473-3099(21)00251-6.
APA
Hamilton, W. L., Fieldman, T., Jahun, A., Warne, B., Illingworth, C. J. R., Jackson, C., Blane, B., Moore, E., Weekes, M. P., Peacock, S. J., De Angelis, D., Goodfellow, I., Gouliouris, T., & Török, M. E. (2021). Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19. The Lancet. Infectious Diseases, 21(7), 916–917. https://doi.org/10.1016/S1473-3099(21)00251-6
Chicago
Hamilton, William L, Tom Fieldman, Aminu Jahun, Ben Warne, Christopher J R Illingworth, Chris Jackson, Beth Blane, et al. 2021. “Applying Prospective Genomic Surveillance to Support Investigation of Hospital-Onset COVID-19.” The Lancet. Infectious Diseases 21 (7): 916–17. doi:10.1016/S1473-3099(21)00251-6.